Fundz

Lucy Therapeutics, Inc. reported raising $2.91 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEJul 15, 2019$2.9M of $3.5M raised

Amount Raised

$2.91 Million

$2.91 Million sold, per SEC Form D (first sale Jul 15, 2019)

Round Type

Seed

WalthamHealthcareBiotechnology Research

Quick answer

Lucy Therapeutics, Inc. raised $2.91 Million in a Seed round, dated July 15, 2019. Lucy Therapeutics, Inc. is based in Waltham, Massachusetts, United States.

How much did Lucy Therapeutics, Inc. raise?
Lucy Therapeutics, Inc. raised $2.91 Million in a Seed round on July 15, 2019.
What does Lucy Therapeutics, Inc. do?
Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis.
Where is Lucy Therapeutics, Inc. based and how big is it?
Lucy Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Lucy Therapeutics, Inc?
Fundz holds 1 contact at Lucy Therapeutics, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology Research around the same time

Companies in the same sectors as Lucy Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Alertgy raised $250K on June 11, 2019.
  • Gravid Therapies, Inc. raised $100K (Pre-Seed) on August 29, 2019.
  • Raleigh Radiology, LLC raised $892K (Seed) on August 29, 2019.
  • Huso, Inc. raised $1M (Seed) on August 29, 2019.
  • Venus Concept Ltd. raised $14M on August 29, 2019.
  • Apollo Med Innovations, Inc. raised $235K (Seed) on August 28, 2019.

Who to call at Lucy Therapeutics, Inc., and when

A new round usually means Lucy Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lucy Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lucy Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lucy Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lucy Therapeutics, Inc.

Location

21 Hickory Drive, Suite 2B

Waltham, Massachusetts, United States

About

Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. LucyTx’s unique approach recognizes that improvement of mitochondrial function early in disease will lead to disease modification as opposed to late-stage symptomatic treatments being pursued by many others. Mitochondrial improvement effects multiple downstream effectors that are essential to disease initiation and progression. Our targets have been validated as neuroprotective in multiple animal models. Key to our strategy is a novel dosing regimen which will mimic effects known to be protective for both neurological and cardiovascular events implicated in key CNS diseases. LucyTx proposes to focus on the orphan disease Rett Syndrome for a proof of concept; we will also explore applications of our technology to Parkinson’s and other CNS diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lucy Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAmy R., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lucy Therapeutics, Inc.'s next move

See what Strategic adds

Lucy Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.